Similar content being viewed by others Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are established therapies for type 2 diabetes (T2DM), exerting their effects through glucose-dependent insulin secretion, suppression of glucagon release, delayed gastric emptying, and central regulation of appetite [1]
The intake is quiz-based: complete an online health questionnaire, licensed clinician reviews it, and if eligible the prescription ships to your door
(Lausanne) 12, 622737
You might have read about GLP-1 drugs and wondered whether they might be a good option for you
The MHRA has issued specific safety guidance on both medicines, and if the combination is clinically unavoidable, a baseline ECG and electrolyte check should be discussed with a prescribing clinician
Other factors, such as taking the medication on an empty stomach or consuming large meals immediately afterward, can intensify nausea